By - Money Matters

Coinbase and Mersana: A Tale of Giants 2023

The Nasdaq Composite moved lower, with Coinbase Global and Mersana Therapeutics playing significant roles

Image by Unsplash

Coinbase Global's shares went down 5% due to falling crypto prices and regulatory pressure

Image by Unsplash

Bitcoin fell by more than $1,000, dropping below $25,000, and Ethereum lost roughly $100 to around $1,640, impacting Coinbase's trading fee

Image by Unsplash

Coinbase faces a regulatory threat from the U.S. Securities and Exchange Commission, which could take months or even years to resolve

Image by Unsplash

Mersana Therapeutics lost 58% due to bad news from the U.S. Food and Drug Administration (FDA) about their ovarian cancer treatment

Image by Unsplash

Five fatal bleeding events among the 560 patients in the trial led to the FDA placing a partial clinical hold on Mersana's trials​

Image by Unsplash

Despite the setbacks, both companies strive to overcome their challenges. Stay tuned for more updates in this financial roller coaster

Image by Unsplash

Follow for More Web Stories

Scribbled Arrow